Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jacob Schlossman"'
Autor:
Jacob Schlossman, Daniel Ro, Shirin Salehi, Daniel Chow, Wengui Yu, Peter D. Chang, Jennifer E. Soun
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
PurposeDespite the availability of commercial artificial intelligence (AI) tools for large vessel occlusion (LVO) detection, there is paucity of data comparing traditional machine learning and deep learning solutions in a real-world setting. The purp
Externí odkaz:
https://doaj.org/article/120ff40fda3544b79bffecf3224f4087
Autor:
Akifumi Hagiwara, Talia C Oughourlian, Nicholas S Cho, Jacob Schlossman, Chencai Wang, Jingwen Yao, Catalina Raymond, Richard Everson, Kunal Patel, Sergey Mareninov, Fausto J Rodriguez, Noriko Salamon, Whitney B Pope, Phioanh L Nghiemphu, Linda M Liau, Robert M Prins, Timothy F Cloughesy, Benjamin M Ellingson
Publikováno v:
Neuro-oncology, vol 24, iss 6
Neuro Oncol
Neuro Oncol
Background Diffusion MRI estimates of the apparent diffusion coefficient (ADC) have been shown to be useful in predicting treatment response in patients with glioblastoma (GBM), with ADC elevations indicating tumor cell death. We aimed to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c76e843c8f23f82a9accfa7560b644b
https://escholarship.org/uc/item/3236b823
https://escholarship.org/uc/item/3236b823
Autor:
Whitney B. Pope, Catalina Raymond, Ararat Chakhoyan, Matthew Ji, Caleb Tan, Timothy F. Cloughesy, Jacob Schlossman, Linda M. Liau, Benjamin M. Ellingson, Albert Lai, Noriko Salamon, Jingwen Yao, Phioanh L. Nghiemphu
Publikováno v:
Journal of neuro-oncology, vol 142, iss 3
J Neurooncol
J Neurooncol
PurposeThe objective of the current study was to explore the efficacy of using pH-weighted amine CEST-EPI as a potential non-invasive imaging biomarker for treatment response and/or failure in recurrent GBM patients treated with bevacizumab.MethodA t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ecfcc79c91ff054d15a406b55e512
https://doi.org/10.1007/s11060-019-03132-z
https://doi.org/10.1007/s11060-019-03132-z
Autor:
Chencai Wang, Kunal S. Patel, Jian Campian, Timothy F. Cloughesy, Shan Rizvi, Patrick Y. Wen, Noa Lowenton-Spier, Leor Zach, Andrew Brenner, Tamar Rachmilewitz Minei, Yael C Cohen, Nicholas Butowski, Benjamin M. Ellingson, Catalina Raymond, John de Groot, Jacob Schlossman, Shifra Fain Shmueli
Publikováno v:
Neuro-oncology advances, vol 3, iss 1
Neuro-oncology Advances
Neuro-oncology Advances
Background Evidence from single and multicenter phase II trials have suggested diffusion MRI is a predictive imaging biomarker for survival benefit in recurrent glioblastoma (rGBM) treated with anti-VEGF therapy. The current study confirms these find
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33780ff3ae4736d8bd0e2fe95b2f023
https://escholarship.org/uc/item/05g831w8
https://escholarship.org/uc/item/05g831w8
Autor:
Shan Rizvi, Kunal S. Patel, Jian Campian, Leor Zach, Catalina Raymond, Chencai Wang, Timothy F. Cloughesy, Jacob Schlossman, Nicholas Butowski, Yael Cohen, Noa Lowenton-Spier, Andrew Brenner, John de Groot, Benjamin M. Ellingson, Tamar Rachmilewitz Minei, Shifra Fain-Shmueli, Patrick Y. Wen
Publikováno v:
Neuro Oncol
BACKGROUND Evidence from independent single center as well as multicenter phase II trials have suggested diffusion MRI is a strong predictive imaging biomarker for survival benefit in recurrent glioblastoma (rGBM) treated with anti-VEGF monotherapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29489d2f1ae5aad4638947e3c7699b56
https://europepmc.org/articles/PMC7651187/
https://europepmc.org/articles/PMC7651187/
Autor:
Timothy F. Cloughesy, Richard Everson, Kunal S. Patel, Jodi Goldman, Albert Lai, Caleb Tan, Jacob Schlossman, Phioanh L. Nghiemphu, Matthew Ji, Benjamin M. Ellingson, Catalina Raymond, Joseph Tsung, Linda M. Liau, Whitney B. Pope, Nhung T Nguyen, Jingwen Yao
Publikováno v:
Neurosurgery, vol 87, iss 5
Neurosurgery
Neurosurgery
BackgroundDiffusion magnetic resonance (MR) characteristics are a predictive imaging biomarker for survival benefit in recurrent glioblastoma treated with anti-vascular endothelial growth factor (VEGF) therapy; however, its use in large volume recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecbf08bf686b1401aeb265417dda4dfa
https://escholarship.org/uc/item/6pd953p6
https://escholarship.org/uc/item/6pd953p6
Autor:
Matthew Ji, Albert Lai, Hiroyuki Tatekawa, Benjamin M. Ellingson, Whitney B. Pope, Jacob Schlossman, Timothy F. Cloughesy, Catalina Raymond, Talia Oughourlian, Jingwen Yao, Johannes Czernin, Phioanh L. Nghiemphu, Noriko Salamon
Publikováno v:
Journal of neuro-oncology, vol 147, iss 1
PurposeTo examine whether the rate of change in maximum 18F-FDOPA PET uptake and the rate of change in non-enhancing tumor volume could predict malignant transformation and residual overall survival (OS) in low grade glioma (LGG) patients who receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff80ab31e4afacec97bb409319ea6aca
https://escholarship.org/uc/item/2464v71k
https://escholarship.org/uc/item/2464v71k
Autor:
Elizabeth George, Javier Villanueva-Meyer, Raymond Y. Huang, Geoffrey S. Young, Jacob Schlossman, Susan M. Chang, Talia Oughourlian, Mary Jane Lim-Fat, Benjamin M. Ellingson, Michael Weller, Catalina Raymond, Patrick Y. Wen, Bryan Iorgulescu, David A. Reardon, Tyler Gleason, Nancy Ann Oberheim Bush, Timothy F. Cloughesy, Hideho Okada
Publikováno v:
Journal of Clinical Oncology. 38:2521-2521
2521 Background: Despite concerns of immunotherapy-induced inflammatory response during PD1 inhibition, questions remain as to the true incidence of inflammatory response and potential clinical implications. The goals of the project were to use GBM p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed7dacf34c64aa90073f6ff6bff1a6e5
https://doi.org/10.1200/jco.2020.38.15_suppl.2521
https://doi.org/10.1200/jco.2020.38.15_suppl.2521
Autor:
Nicholas Butowski, Catalina Raymond, Dror Harats, Jodi Goldman, Andrew Brenner, Yael Cohen, Patrick Y. Wen, Benjamin M. Ellingson, Jacob Schlossman, Timothy F. Cloughesy, Jingwen Yao, Tamar Rachmilewitz Minei, Caleb Tran
Publikováno v:
Neuro Oncol
VB-111 is a non-replicating adenovirus carrying a pro-apoptotic transgene for TNFR1/Fas under the control of a modified murine promoter to pre-proendothelin 1. The transgene is expressed only in angiogenic endothelial cells, and therefore VB-111 resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add0f8215238eadb4dab18efdd1f1429
https://doi.org/10.1093/neuonc/noz175.717
https://doi.org/10.1093/neuonc/noz175.717
Autor:
Dror Harats, Dallas Turley, Ararat Chakhoyan, Nicholas Butowski, Caleb Tan, Yael C Cohen, Andrew Brenner, Jacob Schlossman, Timothy F. Cloughesy, Tamar Rachmilewitz Minei, Jodi Goldman, Benjamin M. Ellingson, Joseph Tsung, Jingwen Yao, Patrick Y. Wen, Catalina Raymond
Publikováno v:
Journal of Clinical Oncology. 37:2018-2018
2018 Background: VB-111 is a non-replicating adenovirus carrying a pro-apoptotic transgene for TNFR1/Fas under the control of a modified murine promoter to pre-proendothelin 1. The transgene is expressed only in angiogenic endothelial cells, and ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d127a9f79cf137c8ff504c061f6f89a5
https://doi.org/10.1200/jco.2019.37.15_suppl.2018
https://doi.org/10.1200/jco.2019.37.15_suppl.2018